APO-Metaraminol metaraminol (as tartrate) 10 mg/1 mL solution for injection ampoule

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

metaraminol tartrate, Quantity: 18.976 mg (Equivalent: metaraminol, Qty 10 mg)

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

Għamla farmaċewtika:

Injection, solution

Kompożizzjoni:

Excipient Ingredients: sodium metabisulfite; water for injections; sodium chloride

Rotta amministrattiva:

Intravenous

Unitajiet fil-pakkett:

5

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,It may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Sommarju tal-prodott:

Visual Identification: clear colorless solution; Container Type: Ampoule; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2019-09-26